• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Biden aides to tell Israelis U.S. will pursue ‘other avenues’ if Iran diplomacy fails

October 5, 2021 by David Barret Leave a Comment

October 5, 2021

By Matt Spetalnick and Steve Holland

WASHINGTON (Reuters) – Top U.S. officials will tell their Israeli counterparts on Tuesday that the Biden administration remains committed to diplomacy with Iran, but if necessary would be prepared to pursue “other avenues” to ensure Tehran does not acquire a nuclear weapon, a senior U.S. official said.

A visit to Washington by Israel’s national security adviser, Eyal Hulata, will allow the two allies to share intelligence and develop a “baseline assessment” of how far Tehran’s nuclear program has advanced, the official said.

Under a 2015 deal, Iran curbed its uranium enrichment program, a possible pathway to nuclear arms, in return for the lifting of economic sanctions. Then-U.S. President Donald Trump quit the deal in 2018 and the Israeli government opposes U.S. efforts to revive it.

In broad terms, U.S. experts believe the time it would take Iran to achieve nuclear “breakout” – enough enriched uranium to build a nuclear bomb – has “gone from about 12 months down to a period of about a few months” since Trump pulled out of the pact, the official said, speaking on condition of anonymity.

“Obviously that is quite alarming,” the official told reporters ahead of Hulata’s talks with U.S. national security adviser Jake Sullivan.

Iran has consistently denied it is developing nuclear weapons.

Echoing President Joe Biden’s comments https://ift.tt/3la9oBV in a White House meeting with Israeli Prime Minister Naftali Bennett in August, the official said: “We of course remain committed to a diplomatic path.”

“But obviously if that doesn’t work there are other avenues to pursue, and we are fully committed to ensuring that Iran never develops a nuclear weapon.”

Asked what actions were under consideration and whether that included military options, the official said “we’ll be prepared to take measures that are necessary” but did not elaborate.

The official said that Iran was “sending indications to a number of parties that they are preparing to come back to Vienna,” where the United States and Iran held indirect talks earlier this year that stalled.

But signaling that obstacles remain, Iran’s foreign minister said https://ift.tt/3A6si0J on Saturday that the United States must first release $10 billion of Tehran’s frozen funds as a sign of good will, something the Biden administration has shown no willingness to do.

Bennett, a far-right politician who ended Benjamin Netanyahu’s 12-year run as prime minister in June, has made clear he wants Biden to harden his stance against Iran, Israel’s regional arch-foe.

There is also disagreement over Biden’s opposition to further expansion of Jewish settlements on occupied land that the Palestinians want for a future state.

Asked whether the issue would be part of Tuesday’s talks, the U.S. official said Israel was well aware of the administration’s view of the need to refrain from actions that could be seen as “provocative” and undermine efforts to achieve a two-state solution between Israel and the Palestinians.

(Reporting By Matt Spetalnick and Steve Holland, Editing by Rosalba O’Brien)

Source Link Biden aides to tell Israelis U.S. will pursue ‘other avenues’ if Iran diplomacy fails

David Barret
David Barret

Related posts:

  1. Wildfire raging in Spain forces more than 900 to flee, a firefighter dies
  2. Amagi tunes into $100M for cloud-based video content creation, monetization
  3. NYC passes bills to improve conditions of app-based delivery workers
  4. Australia should do more to contain housing bubble, climate change-IMF

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Gelada Mothers Fake Fertility To Save Their Babies From Infanticidal Males
  • Newly Discovered Wolf Snake Species Is Slender, Shiny Black, And It’s Named After Steve Irwin
  • First Ever Leopard Bones Found At Provincial Roman Amphitheatre, Suggesting Bloody Gladiatorial Battles
  • The Solar System Might Be Moving Faster Than Expected – Or There’s Something Off With The Universe
  • Why Do People Who Take The “Spirit Molecule” Describe Such Similar Experiences?
  • The Most Devastating Symptom Of Alzheimer’s Finally Has An Explanation – And, Maybe Soon, A Treatment
  • Kissing Has Survived The Path Of Evolution For 21 Million Years – Apes And Human Ancestors Were All At It
  • NASA To Share Its New Comet 3I/ATLAS Images In Livestream This Week – Here’s How To Watch
  • Did People Have Bigger Foreheads In The Past? The Grisly Truth Behind Those Old Paintings
  • After Three Years Of Searching, NASA Realized It Recorded Over The Apollo 11 Moon Landing Footage
  • Professor Of Astronomy Explains Why You Can’t Fire Your Enemies Straight Into The Sun
  • Do We All See The Same Blue? Brilliant Quiz Shows The Subjective Nature Of Color Perception
  • Earliest Detailed Observations Of A Star Exploding Show True Shape Of A Supernova
  • Balloon-Mounted Telescope Captures Most Precise Observations Of First Known Black Hole Yet
  • “Dawn Of A New Era”: A US Nuclear Company Becomes First Ever Startup To Achieve Cold Criticality
  • Meet The Kodkod Of The Americas: Shy, Secretive, And Super-Small
  • Incredible Footage May Be First Evidence Wild Wolves Have Figured Out How To Use Tools
  • Raccoons In US Cities Are Evolving To Become More Pet-Like
  • How Does CERN’s Antimatter Factory Work? We Visited To Find Out
  • Elusive Gingko-Toothed Beaked Whale Seen Alive For First Time Ever
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version